HomeCompareTTNP vs PLD

TTNP vs PLD: Dividend Comparison 2026

TTNP yields 85.47% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $3.80M in total portfolio value· pulled ahead in Year 10
10 years
TTNP
TTNP
● Live price
85.47%
Share price
$2.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.11M
Annual income
$639,398.81
Full TTNP calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — TTNP vs PLD

📍 PLD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTTNPPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TTNP + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TTNP pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TTNP
Annual income on $10K today (after 15% tax)
$7,264.96/yr
After 10yr DRIP, annual income (after tax)
$543,488.99/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,494,627.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TTNP + PLD for your $10,000?

TTNP: 50%PLD: 50%
100% PLD50/50100% TTNP
Portfolio after 10yr
$4.01M
Annual income
$2,695,061.99/yr
Blended yield
67.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TTNP
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Altman Z
-240.6
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TTNP buys
0
PLD buys
0
No recent congressional trades found for TTNP or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTTNPPLD
Forward yield85.47%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$2.11M$5.91M
Annual income after 10y$639,398.81$4,750,725.19
Total dividends collected$1.85M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: TTNP vs PLD ($10,000, DRIP)

YearTTNP PortfolioTTNP Income/yrPLD PortfolioPLD Income/yrGap
1$19,247$8,547.01$11,241$540.96+$8.0KTTNP
2$35,969$15,374.24$13,019$991.13+$22.9KTTNP
3$65,338$26,851.55$15,801$1,870.97+$49.5KTTNP
4$115,497$45,585.62$20,609$3,701.21+$94.9KTTNP
5$198,892$75,309.60$29,919$7,867.97+$169.0KTTNP
6$334,016$121,202.50$50,631$18,617.74+$283.4KTTNP
7$547,628$190,230.15$105,528$51,352.20+$442.1KTTNP
8$877,445$291,482.95$287,364$174,449.42+$590.1KTTNP
9$1,375,345$436,479.30$1,081,760$774,280.77+$293.6KTTNP
10← crossover$2,111,018$639,398.81$5,908,209$4,750,725.19$3.80MPLD

TTNP vs PLD: Complete Analysis 2026

TTNPStock

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

Full TTNP Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TTNP vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TTNP vs SCHDTTNP vs JEPITTNP vs OTTNP vs KOTTNP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.